Navigation Links
Registration Open for OpenClinica European Summit - April 14, 2009
Date:1/20/2009

Event in Brussels to bring together community around OpenClinica open source clinical trial software.

Brussels, Belgium (PRWEB) January 20, 2009 -- Akaza Research announces the first annual OpenClinica European Summit. The event will be held on April 14, 2009 in Brussels, Belgium and bring together users, developers, and leading service providers of the OpenClinica open source electronic data capture (EDC) software.

The Summit is open to the public and will feature engaging presentations by clinical trial sponsors, contract research organizations, academic and government research institutions, and providers of EDC-related services. Conference session formats will include case studies, panel discussions, sessions for end-users as well as system administrators and developers. The keynote presentation will be given by Akaza's CEO Cal Collins.

"This is an exciting time for OpenClinica users in Europe," said Mr. Collins. "The rapid growth in the software's popularity and use in clinical trials by European organizations should make this a very productive and informative event. I look forward to engaging with our European community about OpenClinica's developments and direction."

For more information and to register for the event, see http://www.openclinica.org/European_Summit.html.

Early bird deadline for registration is January 30, 2009.

About OpenClinica®
OpenClinica is open source, web-based clinical trials software for electronic data capture (EDC) and clinical data management (CDM). OpenClinica facilitates study protocol configuration, data collection via electronic case report forms (eCRFs), and enables productive clinical trials management. OpenClinica supports HIPAA, 21 CFR Part 11, and other regulator guidelines and is designed as a lightweight, standards-based, extensible, and modular platform. All versions of OpenClinica are available for free download from http://www.openclinica.org.

About Akaza Research®
Akaza Research, the leading provider of open source clinical trial software, is headquartered in Cambridge, Massachusetts. Supported by the National Institutes of Health (NIH), Akaza has developed and commercialized OpenClinica, the he world's most popular open source clinical research software. Akaza brings Open Source Software (OSS) into the mainstream of the clinical research enterprise by making robust, flexible, standards-based systems accessible for all types of clinical research. Akaza Research provides OpenClinica support, training, hosting and other value added services to its customers worldwide. See www.akazaresearch.com.

# # #

Read the full story at http://www.prweb.com/releases/2009/01/prweb1885874.htm.


'/>"/>
Source: PRWeb
Copyright©2009 Vocus, Inc.
All rights reserved  

Related biology technology :

1. ARYx Therapeutics, Inc. Files Registration Statement for Initial Public Offering
2. Anacor Files Registration Statement for Initial Public Offering
3. Spectrum Pharmaceuticals Initiates Second Registrational Phase 3 Clinical Trial for EOquin(R) in Patients With Non-Invasive Bladder Cancer
4. MAKO Surgical Corp. Files Registration Statement for Initial Public Offering of Common Stock
5. SyntheMed Files Universal Shelf Registration
6. National Stem Cell Holding, Inc. Posts Company and Financial Information on the OTCIQ and Has Retained New CFO and Counsel to File Registration Statement With SEC
7. Reliant Pharmaceuticals Announces the Filing of Registration Statement on Form S-1 For an Initial Public Offering
8. /CORRECTION//- RxElite Temporarily Suspends Sales Under Its Registration Statement
9. Omeros Corporation Files Registration Statement for Proposed Initial Public Offering
10. VaxGen and Raven Announce Form S4 Registration Statement Declared Effective
11. Marketing and Meeting Details (M2D) Offers Customized Convention Registration and Management Tool to Clients Inside and Outside of Pharma/Biotech
Post Your Comments:
*Name:
*Comment:
*Email:
Related Image:
Registration Open for OpenClinica European Summit - April 14, 2009
(Date:4/29/2016)... ... April 29, 2016 , ... ... used in spinal surgical procedures, today announced the completion of a significant transaction ... for current and future customers and partners. Kohlberg & Company, L.L.C. (“Kohlberg”), ...
(Date:4/29/2016)... , April 29, 2016 ... by Transparency Market Research "Separation Systems for Commercial ... Growth, Trends, and Forecast 2015 - 2023", the ... at US$ 10,665.5 Mn in 2014 and is ... from 2015 to 2023 to reach US$ 19,227.8 ...
(Date:4/29/2016)... ... 29, 2016 , ... During a two day program for ... company, CereScan’s CEO, John Kelley, joined other Denver business leaders in providing business ... the Denver area business community, shared his top fundamental learnings in building an ...
(Date:4/29/2016)... CA (PRWEB) , ... April 29, 2016 , ... Summit ... (NSCF) to support the development of a patient-specific stem cell therapy for the treatment ... the lab of Dr. Jeanne Loring at The Scripps Research Institute in San Diego, ...
Breaking Biology Technology:
(Date:4/14/2016)... Israel , April 14, 2016 ... Authentication and Malware Detection, today announced the appointment of ... assumed the new role. Goldwerger,s leadership appointment ... on the heels of the deployment of its platform ... BioCatch,s behavioral biometric technology, which discerns unique cognitive and ...
(Date:3/31/2016)...   LegacyXChange, Inc. ... LegacyXChange is excited to release its first ... be launched online site for trading 100% guaranteed authentic ... also provide potential shareholders a sense of the value ... industry that is notorious for fraud. The video is ...
(Date:3/29/2016)... , March 29, 2016 LegacyXChange, ... LegacyXChange "LEGX" and SelectaDNA/CSI Protect are pleased to announce ... used in a variety of writing instruments, ensuring athletes ... originally created collectibles from athletes on LegacyXChange will be ... of the DNA. Bill Bollander , ...
Breaking Biology News(10 mins):